Picture of Corcept Therapeutics Incorporated logo

CORT — Corcept Therapeutics Incorporated News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareAdventurousLarge CapHigh Flyer

Brief: Corcept Therapeutics Q1 EPS USD 0.17 Vs. IBES Estimate USD 0.14

May 05 (Reuters) - Corcept Therapeutics Q1 net income USD 20.547 million vs. IBES estimate USD 17.1 million.

Q1 revenue USD 157.214 million vs. IBES estimate USD 177.9 million

outlook FY revenue USD 900-950 million

Recent news on Corcept Therapeutics Incorporated

See all news